FDA Import Refusal 799-3636805-5/20001/1 — Novartis/Oncology Tm
The FDA refused shipment 799-3636805-5/20001/1 from Novartis/Oncology Tm (United States) on February 26, 2026. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75
Refusal Details
- Date
- February 26, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75